CIP Web Site: http://imaging.cancer.gov/
NIH - New Funding Initiatives
- QUICK-TRIALS FOR IMAGING AND IMAGE-GUIDED INTERVENTIONS: EXPLORATORY GRANTS (NCI) (PAR-05-114)
Application receipt dates: August 9, December 9, April 9, 2005 through 2008.
The goal of this program is to fund applications focused on the following areas of research: 1) Phase I or II clinical trials of novel imaging-agents to assure their safety and efficacy, so that further evaluations of the clinical potentials of these agents can proceed; 2) Feasibility studies in image-guided intervention, to establish treatment parameters and early therapeutic efficacy for these methods; and/or 3) Clinical feasibility or "proof-of-principle" studies or clinical trials to demonstrate potential efficacy of promising discoveries in imaging or image-guided therapy methodologies or technologies. Investigators may apply for a maximum of 2 years of funding support using the exploratory or developmental (R21) grant mechanism for up to $250,000 direct costs per year. The anticipated number of awards is three to six per year.
- PILOT STUDIES IN PANCREATIC CANCER (NCI) (PA-05-116)
The Division of Cancer Control and Population Sciences (DCCPS), Division of Cancer Biology (DCB), Division of Cancer Prevention (DCP), and Division of Cancer Treatment and Diagnosis (DCTD) of the National Cancer Institute (NCI) invite Exploratory Grant (R21) and Small Grant (R03) applications relating to the biology, etiology, detection, prevention, and treatment of pancreatic cancer. These are short-term awards intended to provide support for pilot projects, testing of new techniques, and/or development of innovative projects that could provide a basis for more extended research.
- MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AWARD (K23) (PA-05-143)
Standard receipt dates apply.
The goal of the Mentored Patient-Oriented Research Career Development Award (K23) program is to ensure a future cadre of well-trained scientists working in POR areas who will become competitive for NIH research project (R01) grant support. The specific objectives of the Mentored Patient-Oriented Research Career Development Award are to:
1)encourage research-oriented clinicians to develop independent research skills and gain experience in advanced methods and experimental approaches needed to become an independent investigator conducting patient-oriented research; 2) increase the pool of clinical researchers who can conduct patient-oriented studies, capitalizing on the discoveries of biomedical research and translating them to clinical settings; 3) support the career development of investigators who have made a commitment to focus their research endeavors on patient-oriented research.
- NIH ROADMAP (abbreviation RM)
The NIH Roadmap is an integrated vision to deepen our understanding of biology, stimulate interdisciplinary research teams, and reshape clinical research to accelerate medical discovery and improve people's health. Most of the initiatives will begin in FY 2004. Other initiatives will start in FY 2005 and beyond, depending upon the budget and other emerging needs. The three NIH Roadmap themes are as follows: new pathways to discovery, research teams of the future, and re-engineering the clinical research Enterprise.
- HIGH-END INSTRUMENTATION GRANT PROGRAM (NCRR) (PAR-05-124)
Letters of Intent Receipt Date(s): August 15, 2005
Application Receipt Date(s): September 20,2005
The NCRR High-End Instrumentation Grant (HEI) program solicits applications from groups of NIH-supported investigators to purchase a single major item of equipment to be used for biomedical research that costs at least $750,000. The maximum award is $2,000,000. Instruments in this category include, but are not limited to, structural and functional imaging systems, macromolecular NMR spectrometers, high-resolution mass spectrometers, cryoelectron microscopes and supercomputers. The NCRR intends to commit approximately $21 million in FY2006 to fund approximately 11-16 new awards. Awards are for one year and for direct costs only. Cost sharing is not required. Since the cost of the various instruments will vary, it is anticipated that the size of the award also will vary. This Program Announcement will use the NIH S10 mechanism.
- DEVELOPMENT OF PET AND SPECT LIGANDS FOR BRAIN IMAGING (SBIR/STTR AWARD) (NIMH, NIDCD, NIDA, NIA, NINDS) (PA-05-122)
Standard receipt dates apply.
This initiative is intended to stimulate the commercial development of novel radioligands for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging in human brain, and to incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. The NIH institutes listed in this PA are specifically interested in the development of radioligands for molecular targets (e.g., receptors, cell adhesion molecules, intracellular messengers, and disease related proteins) that are of broad interest to the scientific community. These radiotracers will be used for neuroimaging as well as potential biological markers and surrogate endpoints for translational and clinical research, drug discovery and development, and clinical trials. Also appropriate for this PA are applications proposing research and development of new technologies for radiotracer development.
JOB ANNOUNCEMENT: IMAGING SCIENTIFIC EDITOR - NIH IMAGING AGENT DATABASE
ComputerCraft Corporation, Bethesda, Maryland, posted May 26, 2004
Computercraft seeks an experienced imaging scientist / editor to provide scientific leadership in the development and maintenance of a new imaging database project at the National Institutes of Health. The individual will work with NIH staff scientists and extramural advisors onsite at the NIH campus. This diversified and challenging position requires a Ph.D. (strongly preferred) or M.S. degree in imaging sciences or highly related field; additional post-Doctoral or post-Master laboratory experience is desired. For consideration please submit cover letter, resume/CV, salary history, salary requirements, and U.S. employment eligibility (you must currently reside in the U.S. and be eligible to work). Contact Computercraft for details.
Email: firstname.lastname@example.org; Fax: 301-493-1288
Mail: Computercraft, Attn: HR, 6701 Democracy Blvd., Suite 401, Bethesda, Maryland 20817
SCIENTIFIC CURATOR - NIH IMAGING AGENT DATABASE
Computercraft seeks an experienced imaging scientist to provide curatorial responsibilities for implementing and maintaining the NIH imaging agent database. The individual will work with NIH staff scientists and extramural advisors onsite at the NIH campus. Join our team of highly skilled and dedicated professionals as we participate in the development of a new centralized database of in vivo imaging agents. This innovative database will include agents developed for position-emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), ultrasound and optical imaging. The database will be located within the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH). This diversified and challenging position requires a Ph.D. (strongly preferred) or M.S. degree in imaging sciences or highly related field. The successful candidate will have a demonstrable knowledge of the chemistry and developmental process of in vivo imaging agents, experience with current analytical tools in both chemistry and biology, and a working knowledge of the issues associated with the information technology and cheminformatics required to successfully implement this database. The ability to extract and summarize scientific information in a textual format is essential. Contact Computercraft for details.
Fax: (301) 493-1288
Mail: Computercraft, Attn: HR, 6701 Democracy Blvd.,Suite 401, Bethesda, MD 20817
CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof of principle clinical trials. See the web site for details.
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
SOCIETY FOR MOLECULAR IMAGING
September 7-10, 2005, Cologne, Germany
FOURTH INTERNATIONAL CONFERENCE ON THE ULTRASONIC MEASUREMENT AND IMAGING OF TISSUE ELASTICITY, October 16-19, 2005, Lake Travis, Austin TX
2005 IEEE MEDICAL IMAGING CONFERENCE
October 23-29th, 2005, Wyndham El Conquistador Resort, Puerto Rico
ADMETECH IMAGE GUIDED, MINIMALLY INVASIVE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
October 27-29, 2005, Washington, DC
October 27 - Cannon Caucus Room, Capitol Hill
October 28-29 - Loews L'Enfant Plaza Hotel, Washington, D.C.
Conference facilities are limited, and therefore registrations will be accepted on the first-come, first-serve basis.
November 27-December 2, 2005, Chicago, IL
SPIE MEDICAL IMAGING 2006
February 11-16, 2006, San Diego, CA. Abstracts due August 1, 2005
ANNUAL CONFERENCE OF THE ACADEMY OF MOLECULAR IMAGING
March 25-29, 2006, Gaylord Palms Resort, Orlando, Fl
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Ms. Johnnie Smith by return e-mail (email@example.com). Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507